Blocking agents help overcome immune rejection of stem cells in mice

03/3/2011 | Google

Scientists at Stanford University reported in the journal Cell Stem Cell that they were able to overcome immune system rejection of transplanted embryonic stem cells in mice after administering a short-term treatment with three co-stimulatory receptor blocking agents, drugs that "teach" T cells to accept transplanted cells. The finding might allow patients to receive donor cells without requiring them to use immunosuppressive drugs and might help prevent transplanted early-stage cells from turning into tumors.

View Full Article in:

Google

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC